Brighthouse Financial, Inc. (BHFAO) stock analysis
Close on Oct 30, 2026Market cap $2.53BP/E 3.5Yield –
StockData Score
Prices as of Oct 30, 2026How the score works
Weak7 of 30 checks passed
Brighthouse Financial passes 7 of the 30 checks behind our score; 15 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 5/6
- Growth
- 0/6
- Past performance
- 2/6
- Financial health
- 0/6
- Dividend
- 0/6
What stands out
Margin of safety over 20%
The price is 48.3% below fair value, more than the 20% cushion we look for.
Trading below fair value
The share price of $43.92 is below our fair value estimate of $85.00.
P/E below the industry
Brighthouse Financial's P/E of 3.5 is below the Life Insurance median of 10.6.
P/S below the industry
Brighthouse Financial's price-to-sales of 0.38 is below the Life Insurance median of 0.64.
What to watch
Return on equity under 15%
Return on equity was 13.6% over the last twelve months and averaged 7.9% over five years; we look for 15% on both.
Revenue growing under 10% a year
Revenue grew -0.5% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -51.9% a year over the last three fiscal years.
P/E above its 5-year median
Brighthouse Financial's P/E of 3.5 is above its own 5-year median of 3.0.
Valuation5/6
P/E above its 5-year median
Brighthouse Financial's P/E of 3.5 is above its own 5-year median of 3.0.
P/E below the industry
Brighthouse Financial's P/E of 3.5 is below the Life Insurance median of 10.6.
P/S below the industry
Brighthouse Financial's price-to-sales of 0.38 is below the Life Insurance median of 0.64.
P/B below the industry
Brighthouse Financial's price-to-book of 0.39 is below the Life Insurance median of 0.92.
Trading below fair value
The share price of $43.92 is below our fair value estimate of $85.00.
Margin of safety over 20%
The price is 48.3% below fair value, more than the 20% cushion we look for.
Growth0/6
Revenue growing under 10% a year
Revenue grew -0.5% a year over the last three fiscal years, short of the 10% we look for.
EPS growing under 10% a year
Diluted EPS grew -51.9% a year over the last three fiscal years.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing slower than the industry
Revenue grew 2.6% over the last twelve months; the Life Insurance median is 8.0%.
Company guidance
No outlook found in earnings releases from the last twelve months.
Gross margin trend
Banks and insurers do not report gross profit.
Past performance2/6
Return on equity under 15%
Return on equity was 13.6% over the last twelve months and averaged 7.9% over five years; we look for 15% on both.
Return on assets under 1%
Return on assets was 0.3%; for a bank or insurer, 1% or more is considered good.
Return on equity above the industry
Brighthouse Financial's return on equity of 13.6% is above the Life Insurance median of 11.7%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin below its 5-year average
Net margin was 12.5% over the last twelve months, against a 5-year average of 15.4%.
Net margin above the industry
Brighthouse Financial's net margin of 12.5% is above the Life Insurance median of 6.5%.
Financial health0/6
Debt level
Needs debt and equity figures.
Debt trend
Needs a balance sheet from five years ago with positive equity.
Debt coverage
Needs operating cash flow.
Interest coverage
Interest expense is not reported separately.
Short-term liquidity
Insurers do not split assets into current and non-current.
Bankruptcy risk (Altman Z)
The Altman model does not apply to insurers.
Dividend0/6
No dividend
Brighthouse Financial has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$85.00
The share price is 48% below this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/E | 6.8× | 3.0× | 10.6× | $84.81 | 50% |
| P/B | 0.7× | 0.6× | 0.9× | $85.19 | 50% |
| Fair value | $85.00 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- P/E at month end
- Own 5-year median 3.0
- Life Insurance median 10.6
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $42.55M
- Value traded per 1% price move
- $37.55M
Downside
Medium risk
- Typical loss in a bad month
- 16.2%
- Volatility (annualized)
- 41%
- Sharpe ratio, 1 year
- -0.23
- Beta to the S&P 500 (5Y)
- 1.08
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2014 to 2025
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +43.2% | -0.5% | -4.5% | -2.7% | |
| Net income | +11.6% | -51.9% | – | – | |
| EPS, diluted | +23.1% | -51.9% | – | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -6.2% | 7.4% | |
| Return on assets | – | -0.4% | 0.2% | |
| Diluted shares | 120M | 95M | 58M |
Cash use needs five years of cash flow figures
Brighthouse Financial does not report operating cash flow and capital expenditure for each of the last five fiscal years.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 6.4% | 0.03× | 40.96× | 7.4% |
| FY2024 | 8.2% | 0.02× | 47.96× | 7.8% |
| FY2023 | -27.0% | 0.02× | 44.02× | -21.2% |
| FY2022 | 56.4% | 0.03× | 22.47× | 35.8% |
| FY2021 | 33.0% | 0.02× | 14.93× | 9.6% |
| FY2020 | -12.5% | 0.04× | 13.89× | -6.2% |
| FY2019 | -11.3% | 0.03× | 14.17× | -4.8% |
| FY2018 | 9.6% | 0.04× | 14.88× | 6.0% |
| FY2017 | -5.5% | 0.03× | 15.19× | -2.6% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$433.00M
- Cash generatingOperating cash flow above zero$259.00M
- Return on assets improvedROA up on the prior year0.2% → 0.2%
- Earnings backed by cashOperating cash flow above net income$259.00M vs $433.00M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose– → –
- No dilutionShare count did not rise62M → 58M
- Gross margin improvedGross margin up on the prior year– → –
- More efficientAsset turnover rose0.02 → 0.03